AstraZeneca’s Imfinzi garners positive opinion from CHMP for NSCLC treatment

AstraZeneca has reached a crucial milestone as the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a ... Read More